387 related articles for article (PubMed ID: 12634062)
1. Reversible amyloid formation by the p53 tetramerization domain and a cancer-associated mutant.
Lee AS; Galea C; DiGiammarino EL; Jun B; Murti G; Ribeiro RC; Zambetti G; Schultz CP; Kriwacki RW
J Mol Biol; 2003 Mar; 327(3):699-709. PubMed ID: 12634062
[TBL] [Abstract][Full Text] [Related]
2. Disruption of an intermonomer salt bridge in the p53 tetramerization domain results in an increased propensity to form amyloid fibrils.
Galea C; Bowman P; Kriwacki RW
Protein Sci; 2005 Dec; 14(12):2993-3003. PubMed ID: 16260757
[TBL] [Abstract][Full Text] [Related]
3. A novel mechanism of tumorigenesis involving pH-dependent destabilization of a mutant p53 tetramer.
DiGiammarino EL; Lee AS; Cadwell C; Zhang W; Bothner B; Ribeiro RC; Zambetti G; Kriwacki RW
Nat Struct Biol; 2002 Jan; 9(1):12-6. PubMed ID: 11753428
[TBL] [Abstract][Full Text] [Related]
4. Amyloid-like fibril formation of co-chaperonin GroES: nucleation and extension prefer different degrees of molecular compactness.
Higurashi T; Yagi H; Mizobata T; Kawata Y
J Mol Biol; 2005 Sep; 351(5):1057-69. PubMed ID: 16054644
[TBL] [Abstract][Full Text] [Related]
5. Tandem dimerization of the human p53 tetramerization domain stabilizes a primary dimer intermediate and dramatically enhances its oligomeric stability.
Poon GM; Brokx RD; Sung M; Gariépy J
J Mol Biol; 2007 Jan; 365(4):1217-31. PubMed ID: 17113101
[TBL] [Abstract][Full Text] [Related]
6. Unfolding, aggregation, and amyloid formation by the tetramerization domain from mutant p53 associated with lung cancer.
Higashimoto Y; Asanomi Y; Takakusagi S; Lewis MS; Uosaki K; Durell SR; Anderson CW; Appella E; Sakaguchi K
Biochemistry; 2006 Feb; 45(6):1608-19. PubMed ID: 16460008
[TBL] [Abstract][Full Text] [Related]
7. Existence of different structural intermediates on the fibrillation pathway of human serum albumin.
Juárez J; Taboada P; Mosquera V
Biophys J; 2009 Mar; 96(6):2353-70. PubMed ID: 19289061
[TBL] [Abstract][Full Text] [Related]
8. A stable human p53 heterotetramer based on constructive charge interactions within the tetramerization domain.
Brokx RD; Bolewska-Pedyczak E; Gariépy J
J Biol Chem; 2003 Jan; 278(4):2327-32. PubMed ID: 12433927
[TBL] [Abstract][Full Text] [Related]
9. Amyloid-like fibril formation in an all beta-barrel protein. Partially structured intermediate state(s) is a precursor for fibril formation.
Srisailam S; Kumar TK; Rajalingam D; Kathir KM; Sheu HS; Jan FJ; Chao PC; Yu C
J Biol Chem; 2003 May; 278(20):17701-9. PubMed ID: 12584201
[TBL] [Abstract][Full Text] [Related]
10. Congo red populates partially unfolded states of an amyloidogenic protein to enhance aggregation and amyloid fibril formation.
Kim YS; Randolph TW; Manning MC; Stevens FJ; Carpenter JF
J Biol Chem; 2003 Mar; 278(12):10842-50. PubMed ID: 12529361
[TBL] [Abstract][Full Text] [Related]
11. Solution conformation and amyloid-like fibril formation of a polar peptide derived from a beta-hairpin in the OspA single-layer beta-sheet.
Ohnishi S; Koide A; Koide S
J Mol Biol; 2000 Aug; 301(2):477-89. PubMed ID: 10926522
[TBL] [Abstract][Full Text] [Related]
12. Solvent-exposed residues located in the beta-sheet modulate the stability of the tetramerization domain of p53--a structural and combinatorial approach.
Mora P; Carbajo RJ; Pineda-Lucena A; Sánchez del Pino MM; Pérez-Payá E
Proteins; 2008 Jun; 71(4):1670-85. PubMed ID: 18076077
[TBL] [Abstract][Full Text] [Related]
13. Amyloid fibril formation from sequences of a natural beta-structured fibrous protein, the adenovirus fiber.
Papanikolopoulou K; Schoehn G; Forge V; Forsyth VT; Riekel C; Hernandez JF; Ruigrok RW; Mitraki A
J Biol Chem; 2005 Jan; 280(4):2481-90. PubMed ID: 15513921
[TBL] [Abstract][Full Text] [Related]
14. Solution conditions can promote formation of either amyloid protofilaments or mature fibrils from the HypF N-terminal domain.
Chiti F; Bucciantini M; Capanni C; Taddei N; Dobson CM; Stefani M
Protein Sci; 2001 Dec; 10(12):2541-7. PubMed ID: 11714922
[TBL] [Abstract][Full Text] [Related]
15. Fourier transform infrared spectroscopy provides a fingerprint for the tetramer and for the aggregates of transthyretin.
Cordeiro Y; Kraineva J; Suarez MC; Tempesta AG; Kelly JW; Silva JL; Winter R; Foguel D
Biophys J; 2006 Aug; 91(3):957-67. PubMed ID: 16698785
[TBL] [Abstract][Full Text] [Related]
16. Partially unfolded states of beta(2)-microglobulin and amyloid formation in vitro.
McParland VJ; Kad NM; Kalverda AP; Brown A; Kirwin-Jones P; Hunter MG; Sunde M; Radford SE
Biochemistry; 2000 Aug; 39(30):8735-46. PubMed ID: 10913285
[TBL] [Abstract][Full Text] [Related]
17. Amyloid protofilaments from the calcium-binding protein equine lysozyme: formation of ring and linear structures depends on pH and metal ion concentration.
Malisauskas M; Zamotin V; Jass J; Noppe W; Dobson CM; Morozova-Roche LA
J Mol Biol; 2003 Jul; 330(4):879-90. PubMed ID: 12850154
[TBL] [Abstract][Full Text] [Related]
18. A systematic investigation into the effect of protein destabilisation on beta 2-microglobulin amyloid formation.
Smith DP; Jones S; Serpell LC; Sunde M; Radford SE
J Mol Biol; 2003 Jul; 330(5):943-54. PubMed ID: 12860118
[TBL] [Abstract][Full Text] [Related]
19. Fibrils formed in vitro from alpha-synuclein and two mutant forms linked to Parkinson's disease are typical amyloid.
Conway KA; Harper JD; Lansbury PT
Biochemistry; 2000 Mar; 39(10):2552-63. PubMed ID: 10704204
[TBL] [Abstract][Full Text] [Related]
20. Identification of a novel human islet amyloid polypeptide beta-sheet domain and factors influencing fibrillogenesis.
Jaikaran ET; Higham CE; Serpell LC; Zurdo J; Gross M; Clark A; Fraser PE
J Mol Biol; 2001 May; 308(3):515-25. PubMed ID: 11327784
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
